GASTALDI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 941
EU - Europa 657
AS - Asia 609
SA - Sud America 106
AF - Africa 11
OC - Oceania 1
Totale 2.325
Nazione #
US - Stati Uniti d'America 898
SG - Singapore 215
CN - Cina 187
RU - Federazione Russa 118
IT - Italia 117
DE - Germania 115
IE - Irlanda 109
BR - Brasile 88
HK - Hong Kong 85
FI - Finlandia 67
GB - Regno Unito 42
VN - Vietnam 42
IN - India 23
CA - Canada 20
ES - Italia 19
MX - Messico 17
JP - Giappone 15
FR - Francia 14
BE - Belgio 11
PL - Polonia 9
SE - Svezia 7
AR - Argentina 6
AT - Austria 6
BD - Bangladesh 6
CZ - Repubblica Ceca 6
TR - Turchia 6
IQ - Iraq 5
NL - Olanda 5
ID - Indonesia 4
LT - Lituania 4
ZA - Sudafrica 4
IL - Israele 3
KG - Kirghizistan 3
MA - Marocco 3
PY - Paraguay 3
VE - Venezuela 3
AL - Albania 2
EC - Ecuador 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
TN - Tunisia 1
UA - Ucraina 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.325
Città #
Singapore 131
Ashburn 129
Chandler 110
Dublin 109
Dallas 90
Hong Kong 85
Munich 64
Los Angeles 52
Beijing 51
Helsinki 45
Boardman 42
New York 31
Milan 22
Buffalo 21
Moscow 20
Redondo Beach 20
Turku 20
Ho Chi Minh City 18
Pavia 18
São Paulo 18
Tokyo 15
Lawrence 13
Nanjing 13
Princeton 13
Shanghai 13
Wilmington 13
Brooklyn 11
Brussels 11
London 11
Medford 11
Montreal 11
Hanoi 10
Ann Arbor 9
Frankfurt am Main 9
Orem 9
Pune 9
Chicago 8
Nuremberg 7
Poplar 7
Rome 7
San Francisco 7
Santa Clara 7
Stockholm 7
Warsaw 7
Atlanta 6
Brno 6
Düsseldorf 6
Madrid 6
Mexico City 6
Changsha 5
Florence 5
Guangzhou 5
San Jose 5
Seattle 5
Bologna 4
Cagliari 4
Chennai 4
Denver 4
Falkenstein 4
Hebei 4
Houston 4
Hyderabad 4
Jacksonville 4
Lauterbourg 4
Manchester 4
Nanchang 4
Querétaro 4
Shenyang 4
The Dalles 4
Baghdad 3
Bishkek 3
Boston 3
Calgary 3
Cambridge 3
Castelfranco Emilia 3
Fortaleza 3
Hangzhou 3
New Delhi 3
Phoenix 3
Secaucus 3
Woodbridge 3
Xi'an 3
'Asir Region 2
Amsterdam 2
Asunción 2
Bad Sobernheim 2
Barzago 2
Berlin 2
Biên Hòa 2
Buccinasco 2
Carney 2
Council Bluffs 2
Curitiba 2
Dearborn 2
Dhaka 2
Fairfield 2
Fort Worth 2
Franca 2
Jakarta 2
Jiaxing 2
Totale 1.524
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 145
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 110
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 103
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 102
Diagnostics of anti-MAG antibody polyneuropathy 100
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 97
Diagnostics of dysimmune peripheral neuropathies 97
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 90
Letter to Editor 89
Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature 84
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 78
Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing 76
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review 72
Seronegative autoimmune diseases: A challenging diagnosis 71
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 67
Autoantibodies against neuroglial surface antigens: laboratory strategies for their detection and roles in acquired demyelinating syndromes, autoimmune encephalitis and acquired neuromyotonia 67
AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus 66
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 64
Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis 63
Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study 54
Towards a standardised analysis of CSF in inflammatory neuropathies 51
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 49
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 49
Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy 49
Improving laboratory diagnostics in myasthenia gravis 47
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors 45
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis 45
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 44
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis 41
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 40
Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New 38
Neurological complications due to copper deficiency in the context of Wilson disease treatment: a case report with long-term follow-up and review of the literature 36
Movement disorders associated with neuronal antibodies: a data-driven approach 35
Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action 29
Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol 29
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 22
Clustering of Exposome and Lifestyle Data to Support Differential Expression Analysis of Circulating miRNAs in Multiple Sclerosis 15
Insights from the EXPOSITION Study: Exposome-related microRNA Expression and Clinical Outcomes in People with multiple sclerosis 12
Totale 2.371
Categoria #
all - tutte 10.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 5 0 6 1 3 2 4
2021/202265 3 1 1 1 1 1 2 4 5 0 11 35
2022/2023310 26 25 5 33 26 27 0 12 133 7 14 2
2023/2024223 24 25 3 10 11 66 6 29 0 7 8 34
2024/2025732 44 40 35 20 18 52 38 16 179 47 75 168
2025/2026960 119 88 151 258 241 103 0 0 0 0 0 0
Totale 2.371